SCHEMBL6847452

SCHEMBL6847452

Fc1cc2c3c(c1)c1c(n3CCO2)CCNCC1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 9/20 0.64
HTR2A P28223 7/20 0.64
HTR6 P50406 2/20 0.33
KDM4E B2RXH2 2/20 0.31
ALOX15 P16050 2/20 0.31
MAPK1 P28482 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6493128 0.99 HTR2C (0.62) HTR2CHTR2AHTR6KDM4EALOX15
SCHEMBL6850266 0.85 HTR2C (0.65) HTR2CHTR2AHTR6KDM4EALOX15
SCHEMBL6847653 0.85 HTR2C (0.65) HTR2CHTR2AHTR6KDM4EALOX15
Hydrochloric Acid SCHEMBL6495767 0.84 HTR2C (0.64) HTR2CHTR2AHTR6KDM4EALOX15
SCHEMBL6483457 0.84 HTR2C (0.64) HTR2CHTR2AKDM4EALOX15MAPK1
SCHEMBL6485279 0.83 HTR2C (0.60) HTR2CHTR2AHTR6MEN1TP53
SCHEMBL6492988 0.81 HTR2C (0.60) HTR2CHTR2AHTR6KDM4EALOX15
SCHEMBL6506794 0.79 HTR2C (0.45) HTR2CHTR2AHTR6KDM4EALOX15
SCHEMBL6847402 0.78 HTR2C (0.53) HTR2CHTR2A
Hydrochloric Acid SCHEMBL6496265 0.78 HTR2C (0.44) HTR2CHTR2AHTR6KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173440-B1 TETRACYCLIC AZEPINOINDOLE COMPOUNDS AS 5-HT RECEPTOR LIGANDS UPJOHN CO (US) 2004-09-15 EP claimed
US-20020198190-A1 Tetracyclic azepinoindole compounds PHARMACIA & UPJOHN COMPANY 2002-12-26 US claimed
JP-2002543080-A 2002-12-17 JP claimed
US-6407092-B1 5-HYDROXYTRYPTAMINE MODULATORS AND ANTISEROTONINE AGENTS; TREATING EATING, SEXUAL, SLEEP, NERVOUS SYSTEM, PSYCHOLOGICAL, AND GASTROINTESTINAL DISORDERS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS PHARMACIA & UPJOHN COMPANY 2002-06-18 US claimed
EP-1173440-A1 TETRACYCLIC AZEPINOINDOLE COMPOUNDS AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-01-23 EP claimed
WO-2000064899-A1 TETRACYCLIC AZEPINOINDOLE COMPOUNDS AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2000-11-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198190-A1 Tetracyclic azepinoindole compounds TPH1, AZI2, CYP1A2 HTR2C 24/4885HTR2A 43/4885HTR6 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.